Anika Therapeutics, Inc. (ANIK) NASDAQ
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Anika Therapeutics, Inc.
Address
32 Wiggins Avenue
Bedford, MA 01730
United States of America (the)
Phone
781 457 9000
Website
Sector
Healthcare
Industry
Medical - Devices
Employees
235
First IPO Date
May 03, 1993
Key Executives
| Name | Title | Pay | Year Born |
| Stephen D. Griffin | President, Principal Financial Officer, CEO & Director | 818,148 | 1986 |
| Ian W. McLeod | Senior VP, Chief Accounting Officer & Treasurer | 489,601 | 1966 |
| Cheryl Renee Blanchard | Executive Chair | 1.41M | 1964 |
| Mira Leiwant | Senior Vice President of Regulatory, Quality & Clinical Affairs | 0 | N/A |
| Ben Joseph | Senior Vice President of Commercial | 0 | N/A |
| Lisa Funiciello | VP & Chief Human Resources Officer | 0 | N/A |
| Matthew Hall | Executive Director of Corporate Development & Investor Relations | 0 | N/A |
| James Chase | Senior Vice President of International Sales & Marketing | 0 | N/A |
Description
Anika Therapeutics, Inc. is a company dedicated to joint preservation, innovating and providing early intervention orthopedic care across the globe, including the United States and Europe. Their core focus areas include osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and advanced bone-preserving joint technologies. All of Anika's products are developed, manufactured, and commercialized utilizing their proprietary hyaluronic acid (HA) technology platform. Their comprehensive product lines feature an OA pain management family, which includes established treatments like Monovisc, Orthovisc, Cingal, and Hyvisc, all designed to alleviate discomfort from osteoarthritis. The company's joint preservation and restoration offerings are extensive, comprising approximately 150 bone-sparing joint technology products, alongside solutions for sports medicine soft tissue repair and orthopedic regenerative therapies. Furthermore, Anika leverages its HA expertise in a non-orthopedic product family, developing applications such as adhesion barriers, advanced wound care products, ophthalmic solutions, and ear, nose, and throat treatments. Anika Therapeutics, Inc. was established in 1983 and is based in Bedford, Massachusetts.
